Product
Help
Pricing
About
Jobs
Log in
Get started
Concept
Add to collection
Tazobactam
OpenAlex ID:
C2778266534
Three Decades of β-Lactamase Inhibitors
2010
·
Sarah M. Drawz
, Robert A. Bonomo
·
Clinical Microbiology Reviews
·
2,112
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
2021
·
Mariana Castanheira
, Patricia J Simner
, et al.
·
JAC-Antimicrobial Resistance
·
1,057
PDF
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial
2018
·
Patrick N. A. Harris
, Paul A. Tambyah
, et al.
·
JAMA
·
878
PDF
Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy
2007
·
R. E. Polk
, C. Fox
, et al.
·
Clinical Infectious Diseases
·
739
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
2016
·
David van Duin
, Robert A. Bonomo
·
Clinical Infectious Diseases
·
613
PDF
Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy
2007
·
T. P. Lodise
, B. Lomaestro
, et al.
·
Clinical Infectious Diseases
·
571
Clinically Feasible Biofilm Susceptibility Assay for Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis
2004
·
Samuel M. Moskowitz
, Jessica M. Foster
, et al.
·
Journal of Clinical Microbiology
·
453
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
2012
·
J. M. Dulhunty
, J. A. Roberts
, et al.
·
Clinical Infectious Diseases
·
439
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
2015
·
Joseph Solomkin
, Ellie Hershberger
, et al.
·
Clinical Infectious Diseases
·
437
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
2015
·
Florian M Wagenlehner
, Obiamiwe Umeh
, et al.
·
The Lancet
·
418
Emerging Infections in Burns
2009
·
Ludwik K. Branski
, Ahmed Al-Mousawi
, et al.
·
Surgical Infections
·
412
-Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
2011
·
J. Rodriguez-Bano
, M. D. Navarro
, et al.
·
Clinical Infectious Diseases
·
400
PDF
Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001
2003
·
James A. Karlowsky
, Deborah C. Draghi
, et al.
·
Antimicrobial Agents and Chemotherapy
·
396
Resistance Patterns Among Nosocomial Pathogens
2001
·
Ronald N. Jones
·
CHEST Journal
·
384
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
2013
·
George G. Zhanel
, Phillip Chung
, et al.
·
Drugs
·
381
Antibiotic Susceptibility Among Aerobic Gram-negative Bacilli in Intensive Care Units in 5 European Countries
1999
·
Håkan Hanberger
, J A Garcia-Rodriguez
, et al.
·
JAMA
·
377
Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
2019
·
Marin H Kollef
, Martin Nováček
, et al.
·
The Lancet Infectious Diseases
·
372
Biofilm formation and antibiotic resistance of Klebsiella pneumoniae isolated from clinical samples in a tertiary care hospital, Klaten, Indonesia
2019
·
Hera Nirwati
, Kian Sinanjung
, et al.
·
BMC Proceedings
·
355
PDF
National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002
2004
·
Marilee D. Obritsch
, Douglas N. Fish
, et al.
·
Antimicrobial Agents and Chemotherapy
·
351
Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase Bacteremia
2015
·
Pranita D. Tamma
, Jennifer H. Han
, et al.
·
Clinical Infectious Diseases
·
350
PDF
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial
2018
·
Keith S. Kaye
, Tanaya Bhowmick
, et al.
·
JAMA
·
342
PDF
Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3
2002
·
L. Poirel
, Marek Gniadkowski
, et al.
·
Journal of Antimicrobial Chemotherapy
·
341
Influence of Renal Function on the Pharmacokinetics of Piperacillin/Tazobactam in Intensive Care Unit Patients During Continuous Venovenous Hemofiltration
2005
·
Alazne Arzuaga
, Javier Maynar
, et al.
·
The Journal of Clinical Pharmacology
·
336
Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001)
2004
·
Jeffrey T. Kirby
, Helio S. Sader
, et al.
·
Journal of Clinical Microbiology
·
330
Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center
1996
·
L. B. Rice
, E. C. Eckstein
, et al.
·
Clinical Infectious Diseases
·
325
Show more works
View as search
Works count:
8,926
Citation count:
154,300
Year
Topic
Type